📢 DDReg Knowledge Capsule – Episode [6]⁠Introduces the concept of Translational Biology and explains how this field is accelerating the development of new therapies by creating a continuous feedback loop between laboratory discovery and patient care. The article outlines the multi-stage Translational Biology Pipeline (T0 to T4), which moves findings from basic research through clinical trials and into public health practice. It also identifies several cutting-edge tools and techniques used in this research, such as proteomics, biomarker analysis, and computational modeling, alongside the primary challenges related to funding and regulatory complexity.

📢 DDReg Knowledge Capsule – Episode [6]Strategic Pharmacovigilance Checklist for Biosimilar Safety in 2025," which offers guidance on managing the increasing complexities of biosimilar safety. The article explains that the biosimilar market is rapidly expanding, necessitating robust pharmacovigilance (PV) to ensure patient safety and mitigate risks. It presents a comprehensive checklist covering key areas such as creating unique Risk Management Plans (RMPs), prioritizing immunogenicity oversight, ensuring detailed traceability and product identification, and employing advanced signal detection techniques using AI/ML tools.

📢 DDReg Knowledge Capsule – Episode [5]Overview of the drug approval process in the Chinese pharmaceutical market, highlighting its significance as the world's second-largest. It details the types of drugs approved, including innovative medicines, generics, and traditional Chinese medicines, and identifies the key regulatory bodies, namely the National Medical Products Administration (NMPA) and the Center for Drug Evaluation (CDE). https://resource.ddregpharma.com/blogs/drug-approval-process-in-china-market/

📢 DDReg Knowledge Capsule – Episode [5]Low data doesn’t mean low risk. In this episode, we unpack how PV teams detect signals in low-volume markets, using smarter tools, sharper strategies, and local expertise to keep drug safety ahead of the curve. For mor Visit our bloghttps://resource.ddregpharma.com/blogs/signal-detection-in-low-volume-markets-how-smart-pv-teams-stay-ahead/

📢 DDReg Knowledge Capsule – Episode [4]This DDReg Knowledge Capsule focuses on cybersecurity in connected medical devices, highlighting the critical balance between technological advancement and patient safety. It discusses the evolving landscape of cyber threats and the regulatory frameworks put in place by bodies like the FDA and the Department of Health and Human Services to address these risks.

📢 DDReg Knowledge Capsule – Episode [3]In this episode of the DDReg Knowledge Capsule,introduce point-of-care diagnostics (POC) as a rapidly expanding sector within the in-vitro diagnostics industry. It explains that POC devices facilitate quick medical testing near the patient, leading to faster diagnoses and improved outcomes, particularly in situations where resources are limited.

📢 DDReg Knowledge Capsule – Episode [2]In this episode of the DDReg Knowledge Capsule, we dive into Digital Therapeutics (DTx), highlighting their role in transforming chronic disease management. It details how DTx, which are clinically validated, software-driven interventions, empower patients through personalised, data-driven care, evidence-based behaviour change, and 24/7 accessibility. 📍Stay informed. Stay compliant. Stay ahead.

📢 DDReg Knowledge Capsule – Episode [1]In this episode of the DDReg Knowledge Capsule, we dive into the evolving landscape of Software as a Medical Device (SaMD) — a transformative area in digital health that's reshaping patient care and healthcare delivery.Join us as we explore:
🔹 What qualifies as SaMD under global regulatory frameworks
🔹 Key regulatory guidelines from the FDA, EU MDR, and IMDRF
🔹 Challenges in compliance, risk classification, and cybersecurity
🔹 Real-world examples of SaMD in diagnostics, monitoring, and therapeutics
🔹 How manufacturers can navigate regulatory pathways to ensure safety and efficacyWhether you're a MedTech innovator, regulatory professional, or healthcare stakeholder, this episode offers essential insights into how software is becoming a standalone therapeutic and diagnostic tool.📍Stay informed. Stay compliant. Stay ahead.